| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Department of Molecular Biotherapy Research, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo 170-8455 [N. S., Y. Y., M. N., Y. M., H. H.]; Department of Neurosurgery, Tokyo University, Tokyo 113 [N. S., A. A., T. K.]; and Core Research for Evolutional Science and Technology (CREST), Kawaguchi 332-0012 [T. K.], Japan
Bcl-2 is an oncogene with antiapoptotic function. However, Bcl-2 is converted to a Bax-like death effector by caspases, suggesting that the expression of Bcl-2 may not favor the growth of cancers. We introduced the Bcl-2 gene to gliomas via adenovirus (Adv; Adv-Bcl-2) with the Adv for Fas (Adv-Fas) and the Adv for Fas ligand (Adv-FL) to evaluate the antiapoptotic function of Bcl-2. In U251 glioblastoma cells, Bcl-2 at a low level of expression repressed apoptosis induced by Adv-Fas and Adv-FL, whereas Bcl-2 at a high level of expression did not. On the other hand, Bcl-XL showed antiapoptotic function against Fas-mediated apoptosis, irrespective of its expression level. In glioblastoma cells, induction of Bcl-2 alone at a high level induced apoptosis, whereas induction of Bcl-XL alone did not. As the multiplicity of infection of Adv-Bcl-2 was increased, the quantity of a cleaved product of Bcl-2 increased. Induction of caspase-inhibitory genes (CrmA and p35) inhibited apoptosis induced by Adv-Bcl-2. Induction of Bcl-2 led to alteration of the membrane potential and structure of the mitochondria. In summary, although Bcl-2 at a low level of expression was antiapoptotic, Bcl-2 at a high level of expression was proapoptotic to Fas-mediated apoptosis. Overexpression of Bcl-XL was consistently antiapoptotic to Fas-mediated apoptosis.
This article has been cited by other articles:
![]() |
L. Benimetskaya, J. C. Lai, A. Khvorova, S. Wu, E. Hua, P. Miller, L.-M. Zhang, and C. A. Stein Relative Bcl-2 Independence of Drug-Induced Cytotoxicity and Resistance in 518A2 Melanoma Cells Clin. Cancer Res., December 15, 2004; 10(24): 8371 - 8379. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Allal, L. Waelchli, and M.-A. Brundler Prognostic Value of Apoptosis-Regulating Protein Expression in Anal Squamous Cell Carcinoma Clin. Cancer Res., December 15, 2003; 9(17): 6489 - 6496. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Nutt, J. Chandra, A. Pataer, B. Fang, J. A. Roth, S. G. Swisher, R. G. O'Neil, and D. J. McConkey Bax-mediated Ca2+ Mobilization Promotes Cytochrome c Release during Apoptosis J. Biol. Chem., May 31, 2002; 277(23): 20301 - 20308. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Wang, M. T. Unkila, E. Z. Reineks, and C. W. Distelhorst Transient Expression of Wild-type or Mitochondrially Targeted Bcl-2 Induces Apoptosis, whereas Transient Expression of Endoplasmic Reticulum-targeted Bcl-2 Is Protective against Bax-induced Cell Death J. Biol. Chem., November 16, 2001; 276(47): 44117 - 44128. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, G. Yang, S. Ebara, T. Satoh, Y. Nasu, T. L. Timme, C. Ren, J. Wang, S. A. Tahir, and T. C. Thompson Caveolin-1 Mediates Testosterone-stimulated Survival/Clonal Growth and Promotes Metastatic Activities in Prostate Cancer Cells Cancer Res., June 1, 2001; 61(11): 4386 - 4392. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Chodon, T. Sugihara, H. H. Igawa, E. Funayama, and H. Furukawa Keloid-Derived Fibroblasts Are Refractory to Fas-Mediated Apoptosis and Neutralization of Autocrine Transforming Growth Factor-{beta}1 Can Abrogate this Resistance Am. J. Pathol., November 1, 2000; 157(5): 1661 - 1669. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shirin, E. M. Sordillo, T. K. Kolevska, H. Hibshoosh, Y. Kawabata, S. H. Oh, J. F. Kuebler, T. Delohery, C. M. Weghorst, I. B. Weinstein, et al. Chronic Helicobacter pylori Infection Induces an Apoptosis-Resistant Phenotype Associated with Decreased Expression of p27kip1 Infect. Immun., September 1, 2000; 68(9): 5321 - 5328. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Yang, J. Addai, M. Ittmann, T. M. Wheeler, and T. C. Thompson Elevated Caveolin-1 Levels in African-American versus White-American Prostate Cancer Clin. Cancer Res., September 1, 2000; 6(9): 3430 - 3433. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |